| Literature DB >> 28300373 |
Davide Cusumano1, Maria Luisa Fumagalli2, Francesco Ghielmetti2, Linda Rossi1, Giuliano Grossi3, Raffaella Lanzarotti3, Laura Fariselli4, Elena De Martin2.
Abstract
Gafchromic EBT3 film dosimetry in radiosurgery (RS) and hypofractionated radiotherapy (HRT) is complicated by the limited film accuracy at high fractional doses. The aim of this study is to develop and evaluate sum signal (SS) film dosimetry to increase dose resolution at high fractional doses, thus allowing for use of EBT3 for dose distribution verification of RS/HRT treatments. To characterize EBT3 dose-response, a calibration was performed in the dose range 0.44-26.43 Gy. Red (RC) and green (GC) channel net optical densities were linearly added to produce the SS. Dose resolution and overall accuracy of the dosimetric protocol were estimated and compared for SS,RC, and GC. A homemade Matlab software was developed to compare, in terms of gamma analysis, dose distributions delivered by a Cyberknife on EBT3 films to dose distributions calculated by the treatment planning system. The new SS and conventional single channel (SC) methods were compared, using 3%/1 and 4%/1 mm acceptance criteria, for 20 patient plans. Our analysis shows that the SS dose-response curve is characterized by a steeper trend in comparison with SC, with SS providing a higher dose resolution in the whole dose range investigated. Gamma analysis confirms that the percentage of points satisfying the agreement criteria is significantly higher for SS compared to SC: 95.03% vs. 88.41% (P = 0.014) for 3%/1 mm acceptance criteria and 97.24% vs. 93.58% (P = 0.048) for 4%/1 mm acceptance criteria. This study demonstrates that the SS approach is a new and effective method to improve dosimetric accuracy in the framework of the RS-HRT patient-specific quality assurance protocol.Entities:
Keywords: Gafchromic EBT3; dosimetric verification; radiosurgery/hypofractioned radiotherapy
Mesh:
Year: 2017 PMID: 28300373 PMCID: PMC5689947 DOI: 10.1002/acm2.12045
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
Figure 1Calibration curves for red channel, green channel, and sum signal obtained by analyzing the batch #AO40411301
Figure 2Calibration curves for red channel, green channel, and sum signal obtained by analyzing the validation batch
Figure 3Dose resolution for red channel, green channel, and sum signal obtained analyzing the batch #AO40411301
Figure 4Dose resolution for red channel, green channel, and sum signal obtained analyzing the validation batch
AICc values for RC,GC, and SS, where K is the number of parameters used in the function
| Functional form | K | AICc (RC) | AICc(GC) | AICc (SS) |
|---|---|---|---|---|
|
| 4 | 10.78 | 10.13 | 9.87 |
|
| 4 | 14.36 | 10.36 | 10.02 |
|
| 5 | 13.75 | 12.64 | 12.45 |
|
| 6 | 15.50 | 15.36 | 15.08 |
|
| 5 | 16.23 | 21.25 | 12.54 |
Uncertainty values and related overall accuracy for SC and SS methods
| Type error | Red channel | Green channel | Sum signal |
|---|---|---|---|
| Δmeas | 1.32% | 1.87% | 1.30% |
| Δfilm | 1.10% | 1.13% | 0.92% |
| Δfit | 0.99% | 1.11% | 0.82% |
| Δtot | 1.98% | 2.45% | 1.79% |
Gamma values for single beam
| Single beam |
|
| ||
|---|---|---|---|---|
| SC | SS | SC | SS | |
| 5 Gy | 93.11% | 95.21% | 99.87% | 99.95% |
| 15 Gy | 99.10% | 99.25% | 99.76% | 99.77% |
Gamma values for 20 patient plans
| Method |
|
| ||||
|---|---|---|---|---|---|---|
| γ < l | 1 < γ < 1.5 | γ > 1.5 | γ < l | 1 < γ < 1.5 | γ > 1.5 | |
| Sum signal | 95.03% | 4.17% | 0.80% | 97.24% | 2.36% | 0.39% |
| Single channel | 88.41% | 9.43% | 2.15% | 93.58% | 5.89% | 0.52% |
Gamma values for 20 plans limiting film doses to a maximum value of 4 Gy
| Method | γ < l [20 cGy 1 mm; D < 4 Gy] | γ <l [20 cGy 1 mm; D > 4 Gy] | ||||
|---|---|---|---|---|---|---|
| Average | Standard deviation |
| Average | Standard deviation |
| |
| Sum signal | 92.77 | 2.79 | 0.424 | 91.15 | 6.36 | 0.027 |
| Single channel | 91.37 | 4.89 | 85.33 | 9.80 | ||
Comparison between ion chamber reading (CC01) and SS and SC dose value estimation in the center of the PTV. The mean dose values calculated by the TPS in the whole chamber volume are also reported for further information
| Patient | CCOl(Gy) | SS (Gy) | SC (Gy) | TPS (Gy) | SS‐CC01/CC01 (%) | SC‐CC01/CC01 (%) |
|---|---|---|---|---|---|---|
| 1 | 4.54 | 4.45 | 4.63 | 4.37 | −1.98 | 1.98 |
| 2 | 4.29 | 4.43 | 4.65 | 4.74 | 3.26 | 8.39 |
| 3 | 6.47 | 6.63 | 7.00 | 6.44 | 2.47 | 8.19 |
| 4 | 4.70 | 4.96 | 5.26 | 4.70 | 5.53 | 11.91 |
| 5 | 4.86 | 4.83 | 5.07 | 4.86 | −0.62 | 4.32 |
| 6 | 13.09 | 13.08 | 13.11 | 12.86 | −0.08 | 0.15 |
| 7 | 12.99 | 13.01 | 13.23 | 12.61 | 0.15 | 1.85 |
| 8 | 15.37 | 14.36 | 13.64 | 14.16 | −6.57 | −11.26 |